3 Asian Penny Stocks With Market Caps Larger Than US$90M

As the Asian markets navigate through fluctuating economic conditions, investors are increasingly interested in opportunities that offer both growth and value. Penny stocks, a term often associated with speculative investments, continue to capture attention due to their potential for significant returns when supported by strong financials and solid fundamentals. In this article, we explore several penny stocks from Asia that exhibit financial robustness and may present promising opportunities for those seeking under-the-radar investments with long-term potential.

Let's take a closer look at a couple of our picks from the screened companies.

Goodbaby International Holdings (SEHK:1086)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Goodbaby International Holdings Limited is an investment holding company involved in the design, research and development, manufacturing, marketing, and distribution of children's products across Europe, the Middle East, India, Africa, the Americas, and the Asia Pacific with a market cap of HK$2.32 billion.

Operations: The company's revenue is primarily derived from Car Seats at HK$4.01 billion and Wheeled Goods at HK$3.88 billion, with additional income from Other Categories totaling HK$1.02 billion.

Market Cap: HK$2.32B

Goodbaby International Holdings has demonstrated robust financial performance, with earnings for the first half of 2026 reaching HK$275.2 million, significantly up from HK$105.39 million a year ago. This growth is partly due to tariff refunds from the U.S., enhancing profitability despite a low return on equity of 5.9%. The company maintains strong liquidity, with short-term assets exceeding liabilities and more cash than total debt, while its dividend yield of 14.44% remains unsupported by earnings coverage. Despite high share price volatility and an inexperienced management team, Goodbaby trades at good value relative to peers and industry standards.

• Take a closer look at Goodbaby International Holdings' potential here in our financial health report.
• Learn about Goodbaby International Holdings' future growth trajectory here.

Cryofocus Medtech (Shanghai) (SEHK:6922)

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: Cryofocus Medtech (Shanghai) Co., Ltd. is a medical device company specializing in cryoablation minimally invasive interventional treatment technology and related medical products in China, with a market cap of HK$742.68 million.

Operations: The company generates revenue primarily from its Research and Development of Medical Consumables and Devices segment, totaling CN¥84.84 million.

Market Cap: HK$742.68M

Cryofocus Medtech (Shanghai) faces challenges as a penny stock with declining revenue, reporting CN¥40.68 million for the first half of 2026 compared to CN¥51.11 million the previous year, and a net loss of CN¥15.08 million. Despite being unprofitable, the company has reduced its losses by 22% annually over five years and maintains strong liquidity with short-term assets surpassing liabilities and more cash than debt. The seasoned management team adds stability, while sufficient cash runway supports operations for over three years based on current free cash flow trends, though volatility remains stable at 6%.

• Click here to discover the nuances of Cryofocus Medtech (Shanghai) with our detailed analytical financial health report.
• Evaluate Cryofocus Medtech (Shanghai)'s historical performance by accessing our past performance report.

Rongan PropertyLtd (SZSE:000517)

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: Rongan Property Co., Ltd., along with its subsidiaries, is involved in real estate development and sales in China, with a market capitalization of CN¥6.59 billion.

Operations: The company's revenue primarily comes from housing sales, generating CN¥2.60 billion, followed by property leasing at CN¥84.76 million and building construction contributing CN¥4.11 million.

Market Cap: CN¥6.59B

Rongan Property Co., Ltd. faces significant challenges as it navigates a period of financial difficulty, reporting a steep decline in revenue to CN¥1.03 billion for the first half of 2026 from CN¥3.90 billion the previous year and incurring a net loss of CN¥156.63 million. Despite these setbacks, the company maintains strong liquidity with short-term assets exceeding both long-term and short-term liabilities, and its debt is well-covered by operating cash flow. While trading significantly below estimated fair value, Rongan's negative return on equity highlights ongoing profitability issues amidst stable weekly volatility at 6%.

• Navigate through the intricacies of Rongan PropertyLtd with our comprehensive balance sheet health report here.
• Gain insights into Rongan PropertyLtd's historical outcomes by reviewing our past performance report.

Where To Now?

• Dive into all 1,052 of the Asian Penny Stocks we have identified here.
• Looking For Alternative Opportunities? The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 18 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com